{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:15:00Z","timestamp":1760267700221,"version":"build-2065373602"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"T\u00e9l\u00e9vie-Luxembourg"},{"name":"Waxweiler grant for cancer prevention research"},{"DOI":"10.13039\/501100006672","name":"Action Lions \u201cVaincre le Cancer.\u201d","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006672","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013390","name":"BK21","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013390","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011017","name":"\u201cRecherches Scientifiques Luxembourg (RSL)\u201d association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011691","name":"\u201cRecherche Cancer et Sang\u201d foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011017","name":"RSL","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010411","name":"En H\u00e4erz fir kriibskrank Kanner","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006672","name":"Action LIONS \u201cVaincre le Cancer\u201d","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006672","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004085","name":"MEST","doi-asserted-by":"publisher","award":["2011-0030001"],"award-info":[{"award-number":["2011-0030001"]}],"id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002551","name":"Seoul National University","doi-asserted-by":"publisher","award":["370C-20160062"],"award-info":[{"award-number":["370C-20160062"]}],"id":[{"id":"10.13039\/501100002551","id-type":"DOI","asserted-by":"publisher"}]},{"name":"SNU"},{"DOI":"10.13039\/501100003725","name":"NRF","doi-asserted-by":"publisher","award":["019R1A2C1009231"],"award-info":[{"award-number":["019R1A2C1009231"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013390","name":"Brain Korea (BK21) PLUS program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013390","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.canlet.2019.11.017","type":"journal-article","created":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T12:58:26Z","timestamp":1573736306000},"page":"468-480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Human telomerase reverse transcriptase depletion potentiates the growth-inhibitory activity of imatinib in chronic myeloid leukemia stem cells"],"prefix":"10.1016","volume":"469","author":[{"given":"Cindy","family":"Grandjenette","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Schnekenburger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthoula","family":"Gaigneaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9borah","family":"G\u00e9rard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christo","family":"Christov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aloran","family":"Mazumder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Dicato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0115-4725","authenticated-orcid":false,"given":"Marc","family":"Diederich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.canlet.2019.11.017_bib1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.critrevonc.2014.11.001","article-title":"Mechanisms of resistance to BCR-ABL TKIs and the therapeutic strategies: a review","volume":"93","author":"Yang","year":"2015","journal-title":"Crit. Rev. Oncol.-Hematol."},{"issue":"6","key":"10.1016\/j.canlet.2019.11.017_bib2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s13238-015-0143-7","article-title":"Leukemia stem cells: the root of chronic myeloid leukemia","volume":"6","author":"Zhou","year":"2015","journal-title":"Protein cell"},{"key":"10.1016\/j.canlet.2019.11.017_bib3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13045-014-0061-9","article-title":"The role of telomeres and telomerase in hematologic malignancies and hematopoietic stem cell transplantation,","volume":"7","author":"Wang","year":"2014","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.canlet.2019.11.017_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020606","article-title":"Telomere length maintenance in cancer: at the crossroad between telomerase and alternative lengthening of telomeres (ALT)","volume":"19","author":"De Vitis","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"34","key":"10.1016\/j.canlet.2019.11.017_bib5","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1038\/s41388-019-0872-9","article-title":"Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players","volume":"38","author":"Yuan","year":"2019","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.canlet.2019.11.017_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/genes7090061","article-title":"Telomerase activation in hematological malignancies","volume":"7","author":"Ropio","year":"2016","journal-title":"Genes"},{"issue":"8","key":"10.1016\/j.canlet.2019.11.017_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/genes7080043","article-title":"Telomerase: the devil inside","volume":"7","author":"Kumar","year":"2016","journal-title":"Genes"},{"issue":"4","key":"10.1016\/j.canlet.2019.11.017_bib8","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/sj.onc.1205075","article-title":"Telomeres and telomerase in hematologic neoplasia","volume":"21","author":"Ohyashiki","year":"2002","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.canlet.2019.11.017_bib9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41556-018-0249-2","article-title":"The dynamic nature of senescence in cancer","volume":"21","author":"Lee","year":"2019","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.canlet.2019.11.017_bib10","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1172\/JCI95148","article-title":"Mechanisms and functions of cellular senescence","volume":"128","author":"Herranz","year":"2018","journal-title":"J. Clin. Investig."},{"year":"2006","series-title":"Gene Expression Changes Associated with Progression and Response in Chronic Myeloid Leukemia","author":"Radich","key":"10.1016\/j.canlet.2019.11.017_bib11"},{"issue":"8","key":"10.1016\/j.canlet.2019.11.017_bib12","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nrc.2016.55","article-title":"New prospects for targeting telomerase beyond the telomere","volume":"16","author":"Arndt","year":"2016","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.canlet.2019.11.017_bib13","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.neo.2014.05.009","article-title":"5-aza-2'-deoxycytidine-mediated c-myc Down-regulation triggers telomere-dependent senescence by regulating human telomerase reverse transcriptase in chronic myeloid leukemia","volume":"16","author":"Grandjenette","year":"2014","journal-title":"Neoplasia"},{"key":"10.1016\/j.canlet.2019.11.017_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bcp.2015.11.005","article-title":"4-Hydroxybenzoic acid derivatives as HDAC6-specific inhibitors modulating microtubular structure and HSP90alpha chaperone activity against prostate cancer","volume":"99","author":"Seidel","year":"2016","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.canlet.2019.11.017_bib15","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2174\/1871520614666141202143757","article-title":"Dual induction of mitochondrial apoptosis and senescence in chronic myelogenous leukemia by myrtucommulone A","volume":"15","author":"Grandjenette","year":"2015","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"2","key":"10.1016\/j.canlet.2019.11.017_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23020333","article-title":"The fungal metabolite eurochevalierine, a sequiterpene alkaloid, displays anti-cancer properties through selective sirtuin 1\/2 inhibition","volume":"23","author":"Schnekenburger","year":"2018","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.canlet.2019.11.017_bib17","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.bcp.2010.10.013","article-title":"Sustained exposure to the DNA demethylating agent, 2'-deoxy-5-azacytidine, leads to apoptotic cell death in chronic myeloid leukemia by promoting differentiation, senescence, and autophagy","volume":"81","author":"Schnekenburger","year":"2011","journal-title":"Biochem. Pharmacol."},{"issue":"17","key":"10.1016\/j.canlet.2019.11.017_bib18","first-page":"4175","article-title":"Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body","volume":"59","author":"Yeager","year":"1999","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.canlet.2019.11.017_bib19","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/sj.onc.1205058","article-title":"Alternative lengthening of telomeres in mammalian cells","volume":"21","author":"Henson","year":"2002","journal-title":"Oncogene"},{"issue":"34","key":"10.1016\/j.canlet.2019.11.017_bib20","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1038\/sj.onc.1203078","article-title":"Role of p53 and p21waf1\/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs","volume":"18","author":"Chang","year":"1999","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.canlet.2019.11.017_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12841","article-title":"Integrating cellular senescence with the concept of damage accumulation in aging: relevance for clearance of senescent cells","volume":"18","author":"Ogrodnik","year":"2019","journal-title":"Aging Cell"},{"issue":"3","key":"10.1016\/j.canlet.2019.11.017_bib22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/sctm.17-0175","article-title":"Concise review: chronic myeloid leukemia: stem cell niche and response to pharmacologic treatment","volume":"7","author":"Arrigoni","year":"2018","journal-title":"Stem Cells Transl. Med."},{"issue":"9","key":"10.1016\/j.canlet.2019.11.017_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23092267","article-title":"Oligonucleotides targeting telomeres and telomerase in cancer","volume":"23","author":"Schrank","year":"2018","journal-title":"Molecules"},{"issue":"43","key":"10.1016\/j.canlet.2019.11.017_bib24","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1016\/j.vaccine.2017.09.011","article-title":"Telomerase based anticancer immunotherapy and vaccines approaches","volume":"35","author":"Kailashiya","year":"2017","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.canlet.2019.11.017_bib25","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/sj.onc.1205081","article-title":"Regulation of the human telomerase reverse transcriptase gene","volume":"21","author":"Ducrest","year":"2002","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.canlet.2019.11.017_bib26","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/sj.leu.2400560","article-title":"Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression","volume":"11","author":"Ohyashiki","year":"1997","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.canlet.2019.11.017_bib27","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/cncr.11217","article-title":"Increased telomerase activity is associated with shorter survival in patients with chronic phase chronic myeloid leukemia","volume":"97","author":"Verstovsek","year":"2003","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.canlet.2019.11.017_bib28","doi-asserted-by":"crossref","first-page":"5557","DOI":"10.1007\/s11033-014-3472-3","article-title":"Expression pattern of hTERT telomerase subunit gene in different stages of chronic myeloid leukemia","volume":"41","author":"Amini","year":"2014","journal-title":"Mol. Biol. Rep."},{"issue":"6087","key":"10.1016\/j.canlet.2019.11.017_bib29","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1126\/science.1222394","article-title":"Cancer. Cancer and telomeres\u2013an ALTernative to telomerase","volume":"336","author":"Shay","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.canlet.2019.11.017_bib30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1756-8722-6-26","article-title":"Presence of alternative lengthening of telomeres associated circular extrachromosome telomere repeats in primary leukemia cells of chronic myeloid leukemia","volume":"6","author":"Samassekou","year":"2013","journal-title":"J. Hematol. Oncol."},{"issue":"7","key":"10.1016\/j.canlet.2019.11.017_bib31","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/emboj.2009.42","article-title":"Control of telomere length by a trimming mechanism that involves generation of t-circles","volume":"28","author":"Pickett","year":"2009","journal-title":"EMBO J."},{"issue":"18","key":"10.1016\/j.canlet.2019.11.017_bib32","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/hmg\/10.18.1945","article-title":"Telomere maintenance by telomerase and by recombination can coexist in human cells","volume":"10","author":"Cerone","year":"2001","journal-title":"Hum. Mol. Genet."},{"issue":"18","key":"10.1016\/j.canlet.2019.11.017_bib33","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/hmg\/10.18.1953","article-title":"Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway","volume":"10","author":"Grobelny","year":"2001","journal-title":"Hum. Mol. Genet."},{"issue":"12","key":"10.1016\/j.canlet.2019.11.017_bib34","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1128\/MCB.21.12.3862-3875.2001","article-title":"Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells","volume":"21","author":"Perrem","year":"2001","journal-title":"Mol. Cell. Biol."},{"issue":"10","key":"10.1016\/j.canlet.2019.11.017_bib35","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1158\/0008-5472.CAN-04-0323","article-title":"Telomeric recombination in mismatch repair deficient human colon cancer cells after telomerase inhibition","volume":"64","author":"Bechter","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2019.11.017_bib36","article-title":"Switch telomerase to ALT mechanism by inducing telomeric DNA damages and dysfunction of ATRX and DAXX","volume":"6","author":"Hu","year":"2016","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.canlet.2019.11.017_bib37","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.tibs.2013.07.001","article-title":"Telomerase: central regulator of all of the hallmarks of cancer","volume":"38","author":"Low","year":"2013","journal-title":"Trends Biochem. Sci."},{"issue":"6","key":"10.1016\/j.canlet.2019.11.017_bib38","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1158\/0008-5472.CAN-13-3568","article-title":"Noncanonical functions of telomerase: implications in telomerase-targeted cancer therapies","volume":"74","author":"Li","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2019.11.017_bib39","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.biochi.2015.12.001","article-title":"New surprises from an old favourite: the emergence of telomerase as a key player in the regulation of cancer stemness,","volume":"121","author":"Terali","year":"2016","journal-title":"Biochimie"},{"issue":"1","key":"10.1016\/j.canlet.2019.11.017_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.0040010","article-title":"TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program","volume":"4","author":"Choi","year":"2008","journal-title":"PLoS Genet."},{"issue":"5","key":"10.1016\/j.canlet.2019.11.017_bib41","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1172\/JCI79134","article-title":"Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity","volume":"125","author":"Koh","year":"2015","journal-title":"J. Clin. Investig."},{"issue":"7251","key":"10.1016\/j.canlet.2019.11.017_bib42","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/nature08137","article-title":"Telomerase modulates Wnt signalling by association with target gene chromatin","volume":"460","author":"Park","year":"2009","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.canlet.2019.11.017_bib43","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4161\/auto.4625","article-title":"Beclin 1-independent pathway of damage-induced mitophagy and autophagic stress: implications for neurodegeneration and cell death","volume":"3","author":"Chu","year":"2007","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.canlet.2019.11.017_bib44","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0092-8674(05)80094-7","article-title":"BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein","volume":"75","author":"Pendergast","year":"1993","journal-title":"Cell"},{"issue":"22","key":"10.1016\/j.canlet.2019.11.017_bib45","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1101\/gad.12.22.3499","article-title":"Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization","volume":"12","author":"Diehl","year":"1998","journal-title":"Genes Dev."},{"issue":"24","key":"10.1016\/j.canlet.2019.11.017_bib46","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1101\/gad.854900","article-title":"Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation","volume":"14","author":"Alt","year":"2000","journal-title":"Genes Dev."},{"issue":"9","key":"10.1016\/j.canlet.2019.11.017_bib47","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4161\/cc.3.9.1145","article-title":"The life cycle of C-myc: from synthesis to degradation","volume":"3","author":"Sears","year":"2004","journal-title":"Cell Cycle"},{"issue":"1\u20132","key":"10.1016\/j.canlet.2019.11.017_bib48","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11010-012-1422-8","article-title":"High density lipoprotein cholesterol promotes the proliferation of bone-derived mesenchymal stem cells via binding scavenger receptor-B type I and activation of PI3K\/Akt, MAPK\/ERK1\/2 pathways","volume":"371","author":"Xu","year":"2012","journal-title":"Mol. Cell Biochem."},{"issue":"3","key":"10.1016\/j.canlet.2019.11.017_bib49","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/15384101.2014.1000134","article-title":"Senescence from G2 arrest, revisited","volume":"14","author":"Gire","year":"2015","journal-title":"Cell Cycle"},{"issue":"6","key":"10.1016\/j.canlet.2019.11.017_bib50","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1474-9726.2011.00736.x","article-title":"Oncogenes induce senescence with incomplete growth arrest and suppress the DNA damage response in immortalized cells","volume":"10","author":"Sherman","year":"2011","journal-title":"Aging Cell"},{"issue":"9","key":"10.1016\/j.canlet.2019.11.017_bib51","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/nm.2014","article-title":"A crucial role for adipose tissue p53 in the regulation of insulin resistance","volume":"15","author":"Minamino","year":"2009","journal-title":"Nat. Med."},{"issue":"7374","key":"10.1016\/j.canlet.2019.11.017_bib52","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature10599","article-title":"Senescence surveillance of pre-malignant hepatocytes limits liver cancer development","volume":"479","author":"Kang","year":"2011","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.canlet.2019.11.017_bib53","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nm.4054","article-title":"p16(Ink4a)-induced senescence of pancreatic beta cells enhances insulin secretion","volume":"22","author":"Helman","year":"2016","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.canlet.2019.11.017_bib54","first-page":"S56","article-title":"To clear, or not to clear (senescent cells)? That is the question","volume":"1","author":"Lujambio","year":"2016","journal-title":"Bioessays"},{"issue":"7","key":"10.1016\/j.canlet.2019.11.017_bib55","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41570-019-0108-0","article-title":"The chemistry of senescence","volume":"3","author":"Lozano-Torres","year":"2019","journal-title":"Nat. Rev. Chem."},{"issue":"4","key":"10.1016\/j.canlet.2019.11.017_bib56","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/MOH.0000000000000252","article-title":"Telomerase in hematologic malignancies","volume":"23","author":"Bruedigam","year":"2016","journal-title":"Curr. Opin. Hematol."},{"issue":"5","key":"10.1016\/j.canlet.2019.11.017_bib57","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","article-title":"ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome","volume":"1","author":"Ginestier","year":"2007","journal-title":"Cell stem cell"},{"issue":"4","key":"10.1016\/j.canlet.2019.11.017_bib58","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1349-7006.2011.01864.x","article-title":"Expression of aldehyde dehydrogenase 1 (ALDH1) in endometrioid adenocarcinoma and its clinical implications","volume":"102","author":"Rahadiani","year":"2011","journal-title":"Cancer Sci."},{"issue":"4","key":"10.1016\/j.canlet.2019.11.017_bib59","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.3892\/ijo.2013.1837","article-title":"Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy","volume":"42","author":"Nishikawa","year":"2013","journal-title":"Int. J. Oncol."},{"issue":"9","key":"10.1016\/j.canlet.2019.11.017_bib60","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.4161\/cc.10.9.15486","article-title":"Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform","volume":"10","author":"Marcato","year":"2011","journal-title":"Cell Cycle"},{"issue":"6","key":"10.1016\/j.canlet.2019.11.017_bib61","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.stem.2014.11.014","article-title":"Pushing the limits: defeating leukemia stem cells by depleting telomerase","volume":"15","author":"Kuo","year":"2014","journal-title":"Cell stem cell"},{"issue":"21","key":"10.1016\/j.canlet.2019.11.017_bib62","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V124.21.2322.2322","article-title":"Inhibition of telomerase with imetelstat is detrimental to leukemia stem cells in acute myeloid leukemia (AML)","volume":"124","author":"Bruedigam","year":"2014","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.canlet.2019.11.017_bib63","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1158\/0008-5472.CAN-14-1924","article-title":"Aldehyde dehydrogenase is regulated by beta-catenin\/TCF and promotes radioresistance in prostate cancer progenitor cells","volume":"75","author":"Cojoc","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2019.11.017_bib64","doi-asserted-by":"crossref","first-page":"12465","DOI":"10.1038\/srep12465","article-title":"Blockade of Wnt\/beta-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype","volume":"5","author":"Jang","year":"2015","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.canlet.2019.11.017_bib65","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1158\/0008-5472.CAN-14-2041","article-title":"Wnt\/beta-Catenin small-molecule inhibitor CWP232228 preferentially inhibits the growth of breast cancer stem-like cells","volume":"75","author":"Jang","year":"2015","journal-title":"Cancer Res."},{"issue":"18","key":"10.1016\/j.canlet.2019.11.017_bib66","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1038\/onc.2014.178","article-title":"beta-Catenin-regulated ALDH1A1 is a target in ovarian cancer spheroids","volume":"34","author":"Condello","year":"2015","journal-title":"Oncogene"},{"issue":"27","key":"10.1016\/j.canlet.2019.11.017_bib67","doi-asserted-by":"crossref","first-page":"24258","DOI":"10.1074\/jbc.M110602200","article-title":"Lymphoid enhancer factor-1 blocks adenomatous polyposis coli-mediated nuclear export and degradation of beta-catenin. Regulation by histone deacetylase 1","volume":"277","author":"Henderson","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.canlet.2019.11.017_bib68","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/nrm2654","article-title":"Beta-catenin hits chromatin: regulation of Wnt target gene activation","volume":"10","author":"Mosimann","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.canlet.2019.11.017_bib69","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/ajh.25342","article-title":"Treatment-free remission with first- and second-generation tyrosine kinase inhibitors","volume":"94","author":"Cortes","year":"2019","journal-title":"Am. J. Hematol."},{"issue":"5","key":"10.1016\/j.canlet.2019.11.017_bib70","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00432-018-2604-x","article-title":"Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study","volume":"144","author":"Ross","year":"2018","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.canlet.2019.11.017_bib71","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1200\/JCO.2016.68.2914","article-title":"Long-term follow-up of the French stop imatinib (STIM1) study in patients with chronic myeloid leukemia","volume":"35","author":"Etienne","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.canlet.2019.11.017_bib72","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13045-016-0293-y","article-title":"Telomere length shortening is associated with treatment-free remission in chronic myeloid leukemia patients","volume":"9","author":"Caocci","year":"2016","journal-title":"J. Hematol. Oncol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519305725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383519305725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T15:51:26Z","timestamp":1759593086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383519305725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":72,"alternative-id":["S0304383519305725"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2019.11.017","relation":{},"ISSN":["0304-3835"],"issn-type":[{"type":"print","value":"0304-3835"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human telomerase reverse transcriptase depletion potentiates the growth-inhibitory activity of imatinib in chronic myeloid leukemia stem cells","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2019.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}